188 related articles for article (PubMed ID: 25398679)
1. Exposure to sodium channel-inhibiting drugs and cancer survival: protocol for a cohort study using the QResearch primary care database.
Fairhurst C; Watt I; Martin F; Bland M; Brackenbury WJ
BMJ Open; 2014 Nov; 4(11):e006604. PubMed ID: 25398679
[TBL] [Abstract][Full Text] [Related]
2. Sodium channel-inhibiting drugs and cancer survival: protocol for a cohort study using the CPRD primary care database.
Fairhurst C; Martin F; Watt I; Doran T; Bland M; Brackenbury WJ
BMJ Open; 2016 Sep; 6(9):e011661. PubMed ID: 27601493
[TBL] [Abstract][Full Text] [Related]
3. Sodium channel-inhibiting drugs and survival of breast, colon and prostate cancer: a population-based study.
Fairhurst C; Watt I; Martin F; Bland M; Brackenbury WJ
Sci Rep; 2015 Nov; 5():16758. PubMed ID: 26577038
[TBL] [Abstract][Full Text] [Related]
4. Sodium channel-inhibiting drugs and cancer-specific survival: a population-based study of electronic primary care data.
Fairhurst C; Martin F; Watt I; Bland M; Doran T; Brackenbury WJ
BMJ Open; 2023 Feb; 13(2):e064376. PubMed ID: 36737094
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential for phenytoin: targeting Na(v)1.5 sodium channels to reduce migration and invasion in metastatic breast cancer.
Yang M; Kozminski DJ; Wold LA; Modak R; Calhoun JD; Isom LL; Brackenbury WJ
Breast Cancer Res Treat; 2012 Jul; 134(2):603-15. PubMed ID: 22678159
[TBL] [Abstract][Full Text] [Related]
6. The sodium channel-blocking antiepileptic drug phenytoin inhibits breast tumour growth and metastasis.
Nelson M; Yang M; Dowle AA; Thomas JR; Brackenbury WJ
Mol Cancer; 2015 Jan; 14(1):13. PubMed ID: 25623198
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Value of Voltage-Gated Sodium Channel Inhibitors in Breast, Colorectal, and Prostate Cancer: A Systematic Review.
Martin F; Ufodiama C; Watt I; Bland M; Brackenbury WJ
Front Pharmacol; 2015; 6():273. PubMed ID: 26834632
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. Molecular pharmacology of voltage-gated sodium channel expression in metastatic disease: clinical potential of neonatal Nav1.5 in breast cancer.
Onkal R; Djamgoz MB
Eur J Pharmacol; 2009 Dec; 625(1-3):206-19. PubMed ID: 19835862
[TBL] [Abstract][Full Text] [Related]
10. Anti-metastatic effect of ranolazine in an in vivo rat model of prostate cancer, and expression of voltage-gated sodium channel protein in human prostate.
Bugan I; Kucuk S; Karagoz Z; Fraser SP; Kaya H; Dodson A; Foster CS; Altun S; Djamgoz MBA
Prostate Cancer Prostatic Dis; 2019 Dec; 22(4):569-579. PubMed ID: 30894674
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic approaches targeting prostate cancer progression using novel voltage-gated ion channel blockers.
Sikes RA; Walls AM; Brennen WN; Anderson JD; Choudhury-Mukherjee I; Schenck HA; Brown ML
Clin Prostate Cancer; 2003 Dec; 2(3):181-7. PubMed ID: 15040863
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.
Wang J; Lu Z; Wu C; Li Y; Kong Y; Zhou R; Shi K; Guo J; Li N; Liu J; Song W; Wang H; Zhu M; Xu H
Prostate; 2019 Jan; 79(1):62-72. PubMed ID: 30242862
[TBL] [Abstract][Full Text] [Related]
13. Blocking channels to metastasis: targeting sodium transport in breast cancer.
Brackenbury WJ; Palmieri C
Breast Cancer Res; 2023 Nov; 25(1):140. PubMed ID: 37950273
[TBL] [Abstract][Full Text] [Related]
14. Effect of Voltage-Gated Sodium Channel Inhibitors on the Metastatic Behavior of Prostate Cancer Cells: A Meta-Analysis.
Yildirim-Kahriman S
Pak J Biol Sci; 2023 Jul; 26(8):419-426. PubMed ID: 37937335
[TBL] [Abstract][Full Text] [Related]
15. Voltage-gated sodium channel activity promotes prostate cancer metastasis in vivo.
Yildirim S; Altun S; Gumushan H; Patel A; Djamgoz MBA
Cancer Lett; 2012 Oct; 323(1):58-61. PubMed ID: 22484465
[TBL] [Abstract][Full Text] [Related]
16. Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders.
Mantegazza M; Curia G; Biagini G; Ragsdale DS; Avoli M
Lancet Neurol; 2010 Apr; 9(4):413-24. PubMed ID: 20298965
[TBL] [Abstract][Full Text] [Related]
17. Contribution of functional voltage-gated Na+ channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer: I. Lateral motility.
Fraser SP; Salvador V; Manning EA; Mizal J; Altun S; Raza M; Berridge RJ; Djamgoz MB
J Cell Physiol; 2003 Jun; 195(3):479-87. PubMed ID: 12704658
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor potentiates in vitro metastatic behaviour of human prostate cancer PC-3M cells: involvement of voltage-gated sodium channel.
Uysal-Onganer P; Djamgoz MB
Mol Cancer; 2007 Nov; 6():76. PubMed ID: 18036246
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy and cancer survival: a longitudinal cohort study: protocol paper.
Ranger TA; Burchardt J; Clift AK; Mei WX; Coupland C; Tan PS; Dixon S; Cardwell CR; Hippisley-Cox J
BMJ Open; 2021 Aug; 11(8):e046701. PubMed ID: 34341043
[TBL] [Abstract][Full Text] [Related]
20. The pharmacology of voltage-gated sodium channels in sensory neurones.
Docherty RJ; Farmer CE
Handb Exp Pharmacol; 2009; (194):519-61. PubMed ID: 19655117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
